• DISGENET Version 24.4: What’s New?

    December 5, 2024

    DISGENET, the largest and most extensive gene-disease association network, has released version 24.4, which means new functions and features designed to support your genomics research. DISGENET version 24.4 includes: With these changes, we continue to provide the DISGENET community with reliable sources, accessible data, and actionable tools all within one single platform. Advanced Search The […]

  • DISGENET Version 24.3: What’s New?

    October 8, 2024

    DISGENET, the largest and most extensive gene-disease association network, has released version 24.3, featuring several new additions. DISGENET version 24.3 includes: With these enhancements, DISGENET continues to provide you with reliable sources, accessible data, and actionable tools to support your research all within one platform. The DISGENET AI Assistant We have released a beta version […]

  • Using Genetics to Identify Drug Targets and Maximize Clinical Trial Success

    August 28, 2024

    By leveraging human genetics to identify drug targets with a proven link to disease mechanisms, the probability of clinical trial success greatly increases [1]. Only 10% of drugs that enter phase 1 clinical trials eventually make it to market [2], primarily due to issues related to efficacy or safety that arise later on. These frequent […]

  • DISGENET Academic License: Eligibility, Application & Free Access

    August 2, 2024

    DISGENET is the most extensive and reliable gene-disease association network, providing the latest and most relevant data in the field. It was created by MedBioinformatics. As an academic or not-for-profit researcher, you can access DISGENET’s core biomedical data at no cost. For deeper insights, we offer additional options utilizing state-of-the-art NLP technology. In this blog, we […]

  • DISGENET platform extracting gene–disease associations for drug discovery and repurposing using NLP.

    Accelerating Drug Discovery and Repurposing with Gene–Disease Data and NLP

    July 19, 2024

    In modern drug discovery, gene–disease associations for drug discovery are critical for identifying promising targets and repurposing opportunities. DISGENET leverages NLP in drug discovery to extract and structure genetic and variant information from millions of biomedical publications, providing R&D teams with actionable genomic data for target identification and accelerating the path from research to therapeutic […]

  • DISGENET logo

    DISGENET: The Next Chapter For Disease Genomics Research

    June 19, 2024

    From today, DisGeNET.org and DISGENET plus will become one unified platform found at disgenet.com. DisGeNET has become a cornerstone for bioinformatics research since starting in 2010. As a small team, we have dedicated 15 years to this valuable resource and we are committed to continuously improving the platform for you, our users. As you can […]